Skadden, Arps, Slate, Meagher & Flom, LLP and Arthur Cox LLP advised Strongbridge, while Goodwin Procter LLP and A&L Goodbody LLP advised Xeris on the deal….
- Homepage
- North America
- North America Legal Chronicle
- Xeris Pharmaceuticals’ Acquisition of Strongbridge Biopharma
Xeris Pharmaceuticals’ Acquisition of Strongbridge Biopharma
Tagged: Alex Intile Alison Morris Andrew Goodman Benjamin Jiang Caroline Bullerjahn Caroline Galiatsos Catherine McCarty Chadé Severin Christopher Huntsman Daniel Karelitz Goodwin Procter Graham Robinson Gregg Coughlin Gregory Schuster Jacqueline Klosek James Matarese Janine Jjingo Jennifer Fay Joseph Theis Jr. Kirby Lewis Margaret Beale-Wirsing Maria Raptis Mark Smith Maya Florence Michael Ena Monica Patel Moshe Spinowitz Nathan Brodeur Paul Jin Regina Olshan Resa Schlossberg Sarah Bock Skadden Arps Slate Meager & Flom Stephanie Richards Stephen Waters Strongbridge Biopharma Timothy Nelson Xeris Pharmaceuticals
Author: Martina Bellini
…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here